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ABSTRACT OF THESIS 
 
ASSESSING MALNUTRITION IN LIVER DISEASE PATIENTS BEING 
EVALUATED FOR TRANSPLANT USING THE NUTRITION FOCUSED 
PHYSICAL EXAM 
 
Patients with liver disease have an increased risk for malnutrition because of side 
effects of the disease. The Nutrition Focused Physical Exam (NFPE) was developed 
for nutrition professionals to aid physicians in a nutrition-based diagnosis of 
malnutrition. The purpose of this study was to examine the NFPE for its validity in 
liver disease patients being evaluated for transplant. In addition, the NFPE was used 
to assess incidence and severity of malnutrition in end stage liver disease patients 
and compare these results to already developed malnutrition tools  such as the 
Patient Generated-Subjective Global Assessment (PG-SGA), Triceps Skinfolds 
(TSF), Mid-Arm Circumference (MAC), Lumbar Index, and Total Psoas Muscle 
Area (TPA). The NFPE was found to be highly correlated with PG-SGA results. 
There was a weak correlation between the NFPE and the TSF, MAC, and Lumbar 
Index/TPA, except when comparing the bottom 25% quartile of the Lumbar Index 
to severe malnutrition using the NFPE. This resulted in a moderate correlation. The 
odds-ratio for hospital admission based on malnutrition and severe malnutrition 
were both extremely high (14.571, 18.857 respectively). These preliminary results 
reinforce the significance of the NFPE and the need for additional studies using this 
tool. 
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Chapter 1: Introduction 
End stage organ disease and organ transplantation, is rapidly growing. According 
to the United Network for Sharing Organs, better known as UNOS, there has been a 
19.8% increase in growth of organ transplants since 2012.[1] This is mainly due to an 
increase in deceased donors and changes in medical criteria that would have previously 
resulted in clinicians declining the use of an organ. Since the first organ transplant 
occurred in 1954, over 700,000 people have received transplants offering an extension on 
life in the U.S. [1, 3] Liver transplantation for end stage liver disease (ESLD), is a major 
section of this population. ESLD affects 1 in 10 Americans, or roughly 30 million 
Americans.[3]  The most common causes of liver disease are from the hepatitis virus, 
heavy alcohol use, non-alcoholic fatty liver disease (NAFLD), liver cancer, and 
autoimmune diseases. Patients with NAFLD, liver cancer, and cirrhosis from the hepatitis 
virus are rising in number, and may be related to the obesity epidemic, previous non-
screening of blood products for the hepatitis virus, and drug use in the U.S. [3] 
End stage liver disease can lead to many health complications such as 
ascites/edema which may require paracentesis or draining, decline in kidney function, 
encephalopathy or confusion, enlarged blood vessels, infection, or decline in respiratory 
function.[3] A common complication of end stage liver disease is malnutrition, which can 
greatly affect a patient’s quality of life outcomes.[4-8] Malnutrition is common in 
patients with liver disease because of their increased metabolic demands, side effects of 
the disease such as malabsorption, and changes in eating habits such as decreased 
appetite or nausea. [4, 9, 10] Additionally, mild to moderate malnutrition is common in 
chronic disease such as organ failure, due to the continuous level of inflammation.[11] 
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This mild to moderate degree of malnutrition can advance to severe malnutrition if it is 
left unrecognized or untreated.[12]  
Malnutrition is prevalent in 15-60% of the adult patient population, but many of 
the methods used to assess malnutrition are expensive, unreliable, or have limitations.[12] 
The range for prevalence of malnutrition varies widely due to the differences in patient 
population and tools used to assess malnutrition. Some tools are very in-depth, while 
others are simply based on appetite and weight loss. Common tools used to assess for 
malnutrition are protein levels (albumin and prealbumin), malnutrition screening tools 
which use a questionnaire, or anthropometric measurements such as triceps skin folds 
(TSF), mid-arm circumference (MAC), and hand-grip strength.[11, 12] These tools can 
be affected by medical conditions and inter-observer reliability. These tools can be 
expensive to conduct, leading to inconsistent and potentially unreliable malnutrition 
diagnoses.   
In 2012, the Academy of Nutrition and Dietetics (AND) and the American 
Society for Parenteral and Enteral Nutrition (ASPEN) released a Consensus Statement on 
the identification and documentation of malnutrition in the adult population.[12] 
According to White et al. (2012), “there is currently no universally accepted approach to 
the diagnosis and documentation of adult malnutrition.” White et al. (2012) in 
conjunction with AND and ASPEN, developed a set of parameters and characteristics for 
qualified nutrition professionals to aid physicians in a nutrition-based diagnosis of 
malnutrition. Thus, the Nutrition Focused Physical Exam (NFPE) was created for 
assessing malnutrition in all of the adult patient population. (See Appendix B) 
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Problem Statement 
The focus of this study is to use the Nutrition Focused Physical Exam (NFPE), 
developed by the Academy of Nutrition and Dietetics and American Society for Enteral 
and Parenteral Nutrition, to identify and assess the severity of malnutrition in end stage 
liver disease patients being evaluated for transplant. In addition, the NFPE will be studied 
for its validity and effectiveness in this specific patient population.  
Purpose 
 According to a recent literature search, only one published study has assessed 
malnutrition using the NFPE.[13] This study was conducted in head and neck cancer 
patients and the results may not apply to all patient populations. More studies need to be 
conducted using the NFPE to determine its use in different adult patient populations. This 
study will use the NFPE to assess incidence and severity of malnutrition in ESLD 
patients and compare these results to already developed malnutrition tools.   
 
Research Questions 
1. How does the NFPE relate to current tools such as Patient Generated-
Subjective Global Assessment (PG-SGA), Triceps Skinfolds (TSF), Mid-Arm 
Circumference (MAC), and Lumbar Index/Psoas Muscle Area in End Stage 
Liver Disease Patients? 
2. How prevalent is malnutrition in ESLD patients using the NFPE for 
diagnosis? 
3. How does malnutrition diagnosed using the NFPE relate to patient outcomes? 
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Research Hypotheses 
1. There is a positive correlation between the NFPE and current tools such as 
PG-SGA, MAC, TSF, and the Lumbar Index/Psoas Muscle Area, when 
assessing malnutrition in ESLD patients. 
2. Malnutrition is prevalent in at least half of all ESLD patients using the NFPE 
for diagnosis.  
3. ESLD patients with a malnutrition diagnosis using the NFPE are more likely 
to result in a patient outcome such as hospital admission, decompensation, 
listing for transplant, transplant, and death.  
 
Justification 
 Malnutrition may be prevalent in “ 65-90% of patients with cirrhosis, and in up to 
100% in patients waiting for liver transplantation”.[14] Many side effects of ESLD, such 
as ascites, may mask the incidence and severity of malnutrition in these patients when 
using available methods such as BMI and weight loss.[4, 9, 10] There has been some 
success in previous studies using hand grip strength, MAC, SGA, and TST. However, 
there are still limitations to using these methods.[10, 15]  
 AND and ASPEN developed the NFPE in 2011. The tool shows promise to be 
used successfully in many adult patient populations to assess the incidence and severity 
of malnutrition. However, to our knowledge, there has only been one published study to 
date that used the NFPE to assess malnutrition in the adult population. The NFPE is 
intended to be an affordable, simple, and reliable method for assessing malnutrition and 
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can be used in a variety of patient populations. Therefore, it is imperative to conduct 
more research using the NFPE to assess malnutrition in multiple populations, including 
those with ESLD, and hopefully, establishing this tool as a “gold standard” for assessing 
malnutrition.  
 
Chapter 2: Literature Review 
 
 
Introduction: 
  
 Malnutrition in ESLD patients is a widespread issue that can lead to many health 
complications and poor outcomes in this patient population. Many studies evaluated 
ESLD and the role of malnutrition.[6, 8-10, 14, 16-18] However, there are many 
limitations to these studies, mainly due to the tools used to assess malnutrition. At this 
point in time, there is no “gold standard” tool that is cheap, easy to use, and valid for 
assessing malnutrition. The purpose of this study is to look at ESLD patients being 
evaluated for transplant, and to assess for malnutrition using the NFPE. Liver disease 
diagnosis and a patient’s MELD (model for end stage liver disease) score will also be 
examined in ESLD patients and will be compared to the NFPE results.  
 
End Stage Liver Disease  
 
The most common causes of ESLD are Hepatitis B and C, acute liver failure, 
autoimmune hepatitis, alcoholic liver disease, nonalcoholic fatty liver 
disease/nonalcoholic steatohepatitis, hepatocellular carcinoma, primary biliary cirrhosis, 
and primary sclerosis cholangitis.[2, 3] There are other causes of ESLD, but they are not 
as commonly seen. Table 1 (see below) provides a summary of these diseases. 
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Table 1: Summary of Common Liver Disease Diagnoses[2, 3] 
Type of Liver 
Disease 
Cause of Liver 
Disease 
At Risk 
Populations/Risk 
Factors 
Treatment/Cure 
Hepatitis B and C 
Hepatitis is a virus 
that can be 
transmitted through 
bodily fluids (semen, 
blood, and vaginal 
secretions) 
• IV drug use 
• Unprotected sex
• Body piercings 
• Tattoos 
• Incarceration  
• Hepatitis can be cured spontaneously by 
the body and through pharmaceuticals. 
• There is currently a vaccine for 
Hepatitis B, but not for Hepatitis C. 
• When a patient with the hepatitis virus 
fails treatment, or waits too long to seek 
treatment, it can lead to liver damage and 
ultimately liver failure. This can only be 
treated with transplant.  
Acute Liver Failure 
Drug overdose 
(acetaminophen), 
drug 
toxicity/reaction, 
herbal supplements, 
viruses, cancer, 
metabolic diseases 
• High 
acetaminophen 
use 
• Herbal use 
• Cancers with 
high risk of liver 
metastasis 
development 
• Liver Cancer 
• Metabolic 
Disorders  
• Medications to reverse poisoning 
• Transplant  
Autoimmune 
Hepatitis 
Immune system 
attacks liver cells 
causing inflammation 
and damage 
• Women 
between the ages 
15-40 
• Other 
autoimmune 
diseases 
• Suppress immune system with steroids 
or other immunosuppressant drugs 
• Transplant 
Alcoholic Liver 
Disease 
Alcohol abuse 
• Alcoholics 
• Those with long 
history of 
frequent alcohol 
use 
• Alcohol cessation 
• Transplant  
Nonalcoholic Fatty 
Liver 
Disease/Nonalcoholic 
Steatohepatitis 
Build-up of fat cells 
in the liver 
• Obesity 
• Diabetes 
• High cholesterol
• Unhealthy diet 
• Healthy diet and exercise 
• Weight loss if overweight/obese 
• Transplant 
Hepatocellular 
Carcinoma 
Liver Cancer 
• Pre-existing 
cirrhosis 
• Long term 
hepatitis virus 
• Resection 
• Chemoembolization 
• Ablation 
• Treatment of hepatitis or underlying 
cirrhosis  
• Transplant 
 
 
 
   
Primary Biliary 
Cirrhosis 
Destruction of 
intrahepatic bile 
ducts leads to build 
• Women 
• Middle age 
• Symptom management with 
medications 
• Transplant 
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up of bile and scar 
tissue, damaging the 
liver. 
adults 
• Genetics 
Primary Sclerosis 
Cholangitis 
Blocked bile ducts 
due to scar tissue and 
inflammation leads to 
buildup of bile, 
damaging the liver. 
• Men 
• Genetics 
• Exact cause 
unknown 
• Symptom management with 
medications and surgery 
• Transplant  
Other (less common) 
Wilson’s Disease, 
Hemochromatosis, 
Alpha-1  
Anti-trypsin 
Deficiency, 
Undetermined cause, 
etc.  
• Genetics 
• Lifestyle 
• Treatment based on disease.  
• Transplant 
 
  
ESLD has many different causes and components to its development. The most 
common indication that liver disease has reached end stage or organ failure, is the 
development of decompensation.[16] The development of decompensation in liver 
disease occurs when there is diffuse scarring in the liver and it loses its ability to fully 
function.[3, 10] Decompensation in liver disease results in various health issues such as 
hepatocellular carcinoma (HCC), ascites that may require frequent paracentesis (LVP) or 
drainage, esophageal varices (EV), hepatorenal syndrome (HRS), jaundice, hepatic 
encephalopathy (HE), spontaneous bacterial peritonitis (SBP) and kidney insufficiency. 
While decompensation is a useful indicator of ESLD, many patients do not develop these 
symptoms until later in the disease. Therefore, clinicians have developed additional tools 
and resources, such as MELD Score and Child-Turcotte-Pugh Score, to assess the 
severity of ESLD in transplant patients.   
 
MELD Score and Liver Disease 
 
Until 2001, the tool used to assess the severity of liver disease for organ allocation 
was the Child-Turcotte-Pugh Score (CTP). Using clinic measurements such as: albumin, 
prealbumin, and prothrombin time lab values, and the subjective evaluation of the degree 
Table 1: Summary of Common Liver Disease Diagnoses (continued) [2, 3]
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of ascites and encephalopathy, CTP was used to determine the overall severity of the 
liver disease.[16]  Mayo Clinic developed the model for end stage liver disease (MELD) 
in 2000. MELD was used in patients undergoing the transjugular intrahepatic 
portosystemic shunt (TIPS) procedure as a tool to predict survival.[19] In 2002, UNOS 
adapted the MELD for use in predicting the 3-month mortality of patients awaiting liver 
transplant. Switching from CTP to MELD score decreased mortality on the waiting list 
15% and wait time from 656 to 300 days.[16] In the study conducted by Ahmad, 
Downey, Akoad, and Cacciarelli (2007), they found that Veterans were transplanted 
faster after switching to MELD score for listing, and there was an increase in 
prioritization of sicker patients for transplant on the waiting list.[20] The drastic 
improvement in wait time and decreased mortality on the waiting list, is why MELD 
scores are now seen as superior to CTP in ESLD patients.   
One reason that MELD score is favored for transplant listing is that objective 
data, instead of subjective data like that used in CTP is used to create the score. A score 
from 6-40 is used to rate the severity of illness. This is calculated based on bilirubin, 
prothrombin time, and creatinine lab values.[16, 21] These scores can vary as patient’s 
liver function improves or worsens. UNOS uses this MELD score to prioritize organs to 
sicker patients. The higher the score, the more likely a patient is to be transplanted. 
According to Leise et al. (2011), a MELD score  15 has a favorable benefit-risk ratio for 
transplant and patients with a MELD > 10 should be referred for liver transplant. While 
the MELD score has been shown to decrease liver transplant wait time and improved 
mortality while waiting on the list, there are still drawbacks to the scoring system. One of 
the major drawbacks of the score, is the missing components of nutritional and functional 
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status.[22] With malnutrition being so widespread in this patient population, it is 
important to determine how malnutrition and MELD are related as a potential indicator 
for mortality in ESLD patients waiting for transplant. Limited research with a broad array 
of malnutrition assessment tools makes consistent evaluation difficult. One aspect of this 
study is to find if there is a correlation between MELD score and degree of malnutrition 
in ESLD patients using the recently developed NFPE.  
 
Malnutrition in Liver Disease 
 
 Malnutrition in liver disease is extremely common due to many factors. 
According to Strasser & Vidot (2011), malnutrition may be prevalent “in 65-90% of 
patients with cirrhosis, and in up to 100% in patients waiting for liver transplantation.” 
Malnutrition in ESLD patients has been shown to further complicate their health, by 
increasing their risk of developing infections, ascites, hepatorenal syndrome, and hepatic 
encephalopathy.[9, 14] Understanding the mechanisms and causes of the development of 
malnutrition in cirrhosis patients is key in their prevention and diagnosis.  
Malnutrition in ESLD patients is recognized as a form of undernutrition or 
inadequate intake of nutrients, which can be influenced by a variety of factors. Often, 
resulting in muscle and fat loss, nutrient deficiencies, and poor outcomes. Those with 
ESLD have common nutrition-related side effects that include decreased appetite, early 
satiety due to ascites, abdominal pain with possible nausea and bloating caused by 
decreased gastric motility of indigestion, and impaired absorption secondary to portal 
hypertension and cholestatic liver disease.[10, 17] Impaired absorption from liver disease 
prevents the body from completely absorbing nutrients or foods ingested or decreases the  
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ability to use the nutrients consumed as adequately as the body should. These patients 
also have increased calorie and protein needs due to their hypermetabolic state.[17]  
The hypermetabolic state in ESLD, as a result of chronic inflammation, promotes 
the breakdown of proteins and causes an increase in energy expenditure.[17] The release 
of pro-inflammatory cytokines and alcohol intake leads to a hypermetabolic state 
resulting in poor appetite and anorexia.[9, 17] Anorexia, hypermetabolism, and nutrition-
related side effects from liver disease are important components in the development of 
malnutrition. 
Patients with ESLD are often prescribed different diets based on their diagnosis, 
weight, presence of decompensation, and level of muscle and fat loss. These diets are 
tailored for specific patient needs to help with symptom management and to prevent 
future side effects as the liver disease progresses. A low sodium, high protein diet is the 
general recommendation for liver disease patients to reduce ascites/edema development 
and prevent protein catabolism or breakdown.[10] As ascites increases or appetite 
decreases, patients are recommended to eat small, frequent meals and include a bedtime 
snack to increase calorie and protein intake, thus preventing long periods of fasting. 
Patients with a diagnosis of NASH or NAFLD are recommended to lose weight, while 
consuming adequate amounts of protein due to the catabolic state of their cirrhosis.[10] 
Adhering to these diets can be challenging for patients, and may play a role in the 
development of malnutrition.  
Nutrition-related side effects and hypermetabolism, are not the only factors that 
drive a patient’s malnutrition. The nature of the recommended diet for patients with 
cirrhosis itself can also make it difficult to meet nutritional goals. Maintaining adequate 
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nutrition while following a low sodium diet is especially difficult for ESLD patients.[14] 
Decreased palatability of food without salt and limited number of food options that are 
high in calories and protein but low in sodium can make it difficult for patients to 
maintain a satisfactory nutritional status, especially without the help of nutrition expert. A 
decreased intake of foods and impaired absorption may lead to micronutrient deficiencies 
such as zinc and magnesium, which can lead to taste changes (metallic, foul, rancid) and 
further decrease their intake.[9]  
It is also still commonplace for practitioners to recommend patients follow a low 
protein diet for encephalopathy prevention, even though this was found to be inaccurate, 
and can be detrimental to a patient’s nutritional status.[14, 23] In a randomized study 
conducted by Cordoba et al. in 2004, there was no difference seen in development and 
course of encephalopathy between normal protein and low protein diet groups. 
Furthermore, higher protein catabolism was seen in the patients on the low protein diet, 
providing further evidence of why protein should not be restricted in this population.[24] 
Even with evidence to the contrary, many clinicians still recommend cirrhotic patients 
follow a low-protein diet, either from misinformation or lack of knowledge surrounding 
current research, further complicating their health.  
Protein needs are high in ESLD patients. Their hypermetabolic state leads to an 
increased breakdown of protein, while complications from cirrhosis can lead to increased 
protein losses in ascites, during paracentesis, and in blood loss from varices.[10, 17] The 
decrease in liver function itself, can also lead to decreased protein stores. Cirrhotic livers 
produce an insufficient amount of protein and have reduced capacity to store proteins in 
the liver. A continual decreased intake of protein in liver disease, can drive the body into 
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a metabolic state comparable to starvation.[10, 14] Even an overnight fast without protein 
can throw the body into this “starvation” mode due to the cirrhotic liver’s decreased 
glycogen reserves. These decreased glycogen reserves cause the body to create energy 
through gluconeogenesis and lipolysis.[14] 
When the body uses these alternate sources of fuel, amino acids are pulled from 
the muscle for gluconeogenesis, and fat stores are used for lipolysis.[17] This leads to 
muscle wasting and fat loss that is commonly seen in end stage cirrhotic patients. The 
presence of decompensation also increases the risk of developing malnutrition in liver 
disease patients.[10] The nutrition-related side effects we commonly see in these patients, 
the decreased function of the liver, inability to meet nutritional needs from decreased 
appetite and dietary restrictions, and the high calorie and protein needs all contribute to 
the weight loss, muscle loss, and fat loss seen in ESLD patients. This contributes to, an 
increased risk of developing malnutrition.  
Previous studies have used different methods to assess the degree of malnutrition 
in liver patients. The Subjective Global Assessment (SGA) and anthropometric measures 
such as BMI and weight loss/gain, mid-arm muscle circumference (MAMC), mid-arm 
circumference (MAC), triceps skin fold (TSF), hand grip strength with dynamometer, and 
blood protein levels are all common tools that have been used to assess the degree of 
malnutrition in liver patients.[10, 17] Anthropometrics such as BMI and weight loss/gain 
is especially hard to use as an evaluator of malnutrition due to the large volume of ascites 
that is typically found in ESLD patients. NASH/NAFLD patients are typically obese and 
signs of muscle loss can be masked.[9, 10] Merli et al. (2011) and Johnson et al. (2013) 
discussed how measuring protein stores/levels, such as albumin and prealbumin as 
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indicators of nutritional status, have been used in previous studies but can be unreliable in 
ESLD patients. This is due to the already decreased production of proteins in the liver 
and their response to inflammation. While protein stores, BMI, and weight changes have 
limitations when assessing malnutrition in liver disease patients, there are some tools that 
are fairly useful and can be used in this population.  
The SGA, MAMC, MAC, TSF, and hand grip strength have been relatively 
successful in previous studies for evaluating malnutrition in liver disease patients, but 
still have limitations.[9, 14, 15, 17] MAMC, MAC, and TSF can be good tools to use in 
ESLD because they are not affected by ascites and edema, but there could be inter- and 
intra-observer variability if they are not properly trained. Alveres-Da Silva & Silveira 
(2005), compared hand grip strength, SGA, and nutritional index derived from lab values 
and TSF, and determined that hand grip strength can be a reliable measure, but none of 
these assessment tools can be considered a “gold standard” alone. A simple, cheap, and 
more effective method needs to be developed. The purpose of this study is to explore 
newly developed malnutrition assessment tools in the search of this “gold standard”.   
 
 
Lumbar Index and Muscle Loss 
 
Sarcopenia, or loss of muscle mass, is frequently an issue in chronic illness such 
as ESLD. Muscle loss is often the result of poor nutritional status or malnutrition, a 
common characteristic in cirrhosis patients, and is often used to assess the severity of 
malnutrition. Measuring nutritional status is often unreliable or subjective. Therefore, 
research into measuring sarcopenia with objective tools, such as CT scans, has become of 
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recent interest. These tools are especially useful in this patient population due to ascites 
and fat mass potentially masking evidence of muscle loss. 
A study conducted by Durand et al. (2014) looked at the muscle thickness of the 
psoas muscle to assess for sarcopenia. This muscle is in the lumbar region of the spine 
and was studied at the level of the umbilicus. The psoas muscle has been shown to 
correlate to whole body muscle mass, and is relatively easy to see on scans, making it an 
ideal measure of muscle loss.[25] This study examined psoas muscle thickness in ESLD 
patients waiting for transplant. Decreased psoas muscle thickness were shown to be 
predictive of mortality, independent of MELD score, while on the waiting list. Durand et 
al. (2014), also found this to be true in the patients with lower MELD scores (<25) who 
also had refractory ascites. This is especially important because of the role of MELD and 
ascites in the ESLD patient. Assessing muscle loss in these patients is often difficult due 
to their ascites, and MELD scores do not always accurately reflect mortality risk because 
they lack a nutritional component. MELD scores were also shown to underestimate 
mortality risk in this study and refractory ascites was believed to be a component in the 
development of muscle loss in these patients.[25] However, there are limitations to using 
this tool to assess muscle loss or sarcopenia. These scans are not low in cost, they can be 
affected by osteoporosis or spinal fractures, and they are not as easy to frequently 
reassess in a patient as a MELD score. While this tool is not perfect, is it is very useful as 
an objective tool for measuring sarcopenia in ESLD patients.  
In the study conducted by Montano-Loza et al. (2012), sarcopenia was studied as 
a predictor of mortality compared to MELD scores. The patients used in this study were 
being evaluated for transplant. All patients underwent a routine CT scan as part of their 
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evaluation. The third lumbar (L3) vertebrae was studied on these scans for sarcopenia 
using a skeletal muscle index (SMI).[22] The results of this study showed no correlation 
between sarcopenia and MELD, CTP, or albumin levels in these patients. A higher 
mortality rate was found in the patients with sarcopenia and was related to sepsis-related 
death instead of death from liver failure. When using tools such as MELD/CTP as sole 
indicators of mortality in ESLD patients, without including nutritional or functional 
status, there may be an underestimation in a patient’s risk of mortality.[22] Montano-
Loza et al. (2012) notes that CT scans are considered the “gold standard” for diagnosing 
sarcopenia, but including measurements of muscle function, such as hand-grip strength, 
should be used in the assessment of sarcopenia. These results demonstrate how 
sarcopenia can be used to predict mortality. In addition, sarcopenia could be beneficial in 
determining MELD scores, which could potentially lead to a more accurate reflection of 
mortality risk in ESLD patients. 
In a recent study conducted in the U.K., sarcopenia and malnutrition were 
assessed and compared to MELD scores in ESLD patients to predict post-transplant 
outcomes. Nutritional status and degree of malnutrition were assessed using the validated 
Royal Free Hospital Global Assessment (RFH-GA), a tool that is similar to the SGA, that 
is used frequently in the U.S. This assessment includes subjective and objective measures 
including MAC, TSF, hand grip strength, BMI, and dietary intake.[8] CT scans were 
taken to evaluate L3, including the psoas muscle, and were used in the L3-psoas muscle 
index (L3-PMI) as a means of comparison. L3-PMI was found to be “positively 
correlated with dry weight, BMI, MAC, TSF, handgrip strength, RFH-GA, and MELD” 
in this study. However, there was a wide variance in L3-PMI in patients with similar 
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MELD scores.[8] This shows how nutritional status is not reflected in MELD scores, but 
can be an important predictor of mortality and outcomes. In addition, there was no 
correlation found between MELD and RFH-GA scores. Pre-transplant RFH-GA was 
associated with worse outcomes and survival, independent of MELD scores.[8] 
Kalafetelia et al. (2016) also found that malnutrition and sarcopenia were independent 
predictors for post-transplant complications, such as prolonged mechanical ventilation, 
longer LOS in ICU and hospital, increased rate of infections, and mortality 1-year after 
transplant. RFH-GA even had a stronger correlation with determining post-transplant 
outcomes, than L3-PMI.[8] This shows the importance of using nutritional assessments in 
predicting post-transplant complications. Using valid nutrition assessments such as RFH-
GA, with objective tools used to determine muscle loss such as L3-PMI, can improve the 
mortality prediction of MELD scores in ESLD patients. An easy, reliable, and valid tool 
that encompasses both of these aspects, needs to be developed for use in calculating 
MELD scores to better predict 3-month mortality in cirrhosis patients waiting for 
transplant.[8]  
Recognizing sarcopenia in ESLD patients, is important for their course of 
treatment and reduction of complications associated with malnutrition. However, CT 
scans are extremely expensive, are not feasible for all populations, are not practical to use 
as a frequent tool to monitor sarcopenia, and may be inferior to an overall nutritional 
status, especially as a predictor of post-transplant outcomes. The need for a valid, 
reliable, all-encompassing tool, is important for prevention and reduction of transplant 
outcomes in ESLD patients. 
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Nutrition Focused Physical Exams  
In 2012, AND and ASPEN formed an international work group assisted by the 
European Society for Parenteral and Enteral Nutrition (ESPEN) to standardize markers 
and characteristics of malnutrition. AND and ASPEN later released a consensus 
statement for identifying and assessing malnutrition.[12] Today, there is no “gold 
standard” for identifying malnutrition in the adult patient population. The resources we 
have vary widely. Often, they are subjective. This leads to intra-observer variability. 
They may also not be specific enough to use between different adult population groups. 
When AND and ASPEN released their updated characteristics to detect and diagnose 
malnutrition, inflammation, illness vs. environment, and physical characteristics were 
added to aid in diagnosis. According to White et al. (2012), to identify malnutrition, two 
of the six proposed characteristics need to be present and the characteristics can be 
distinguished between non-severe and severe. These characteristics are located below in 
Table 2. These characteristics should be assessed upon admission and routinely 
throughout patient’s admission/care and should be used to aid physician in diagnosis of 
malnutrition. These characteristics have not been validated and will be updated as 
research is conducted. 
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Table 2: NFPE: Clinical Characteristics to Identify and Support a Diagnosis of 
Malnutrition[26] 
 
Clinical 
Characteristic 
Malnutrition in the context of 
acute illness or injury 
Malnutrition in the context 
of chronic illness 
Malnutrition in the context of 
social or environmental 
circumstances 
  
Non-severe 
(moderate) 
malnutrition 
Severe 
Malnutrition 
Non-severe 
(moderate) 
malnutrition 
Severe 
Malnutrition 
Non-severe 
(moderate) 
malnutrition 
Severe 
Malnutrition 
Energy Intake 
<75% of 
estimated 
energy 
requirement 
for > 7 days 
< 50% of 
estimated 
energy 
requirement 
for  5 days 
< 75% of 
estimated 
energy 
requirement 
for  1 
month 
< 75% of 
estimated 
energy intake 
for  1 
month 
< 75% of 
estimated 
energy 
requirement 
for  3 
months 
£ 50% of 
estimated 
energy 
requirement 
for  1 
month 
Interpretation 
of Weight 
Loss 
% Time % Time % Time % Time % Time % Time 
1-2 1 week >2 1 week 5 
1 
month 
>5 
1 
month 
>5 
1 
month 
>5 
1 
month 
5 
1 
month 
>5 
1 
month 
7.5 
3 
months 
>7.5 
3 
months 
>7.5 
3 
months 
>7.5 
3 
months 
7.5 
3 
months 
>7.5 
3 
months 
10 
6 
months 
>10 
6 
months 
>10 
6 
months 
>10 
6 
months 
       20 1 year >20 1 year >20 1 year >20 1 year 
Physical Findings 
Body Fat Mild Moderate Mild Severe Mild Severe 
Muscle Mass Mild Moderate Mild Severe Mild Severe 
Fluid 
Accumulation 
Mild 
Moderate to 
Severe 
Mild Severe Mild Severe 
Reduced Grip 
Strength 
N/A 
Measurably 
Reduced 
N/A 
Measurably 
Reduced 
N/A 
Measurably 
Reduced 
 
Since the consensus statement was released, there has been very little research 
using the newly defined malnutrition characteristics. In 2016, Mulasi et al. conducted a 
study using the new consensus criteria in head and neck cancer patients who were 
undergoing cancer treatment. They compared the criteria to other nutrition tools such as 
the Subjective Global Assessment (SGA) and bioimpedance methodology to assess for 
muscle loss. The bioimpedance methodology is relatively new and is still being studied 
for validity.[13] The individuals in this study were assessed with the consensus 
characteristics, SGA, and bioimpedance before chemoradiotherapy (CRT) treatment, at 
three weeks after beginning treatment, during the last week of treatment, and one and 
three months after completion of treatment. There was no significant difference found 
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between diagnosis of malnutrition between consensus criteria and SGA. They found good 
sensitivity (94%), and moderate specificity (43%). However, there were limitations to 
this study. There was a very small population in this study (n=19), it was a single-center 
study, and only one participant was female. Many of the components of the NFPE were 
validated through other nutrition tools in this study. More research needs to be conducted 
using validated tools to compare to the physical findings section of the NFPE. 
 
Conclusion 
The purpose of this study is to address the gap in knowledge concerning the 
Nutrition Focused Physical Exam (NFPE) such as limited research using the NFPE and 
its use in ESLD patients. Additionally, the study will test the validity and reliability of the 
NFPE by comparing current, valid, objective tools such as PG-SGA, TST, MAC, and the 
Lumbar Index/Psoas Muscle identified through CT scans. Each of these tools will be used 
to diagnose malnutrition and will be compared against the NFPE results. In addition, this 
tool will be used to identify and assess the severity of malnutrition in ESLD patients 
being evaluated for transplant. The findings of this study will examine the NFPE to 
determine if it’s a valid tool for assessing malnutrition in ESLD patients.  
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Chapter 3: Methods 
Study Design: 
This was a human based, non-intervention, cross-sectional study, for the 
assessment of incidence and severity of malnutrition in end stage liver disease patients 
being evaluated for transplant. Malnutrition was determined using multiple tools including 
the Subjective Global Assessment (SGA), mid-arm circumference (MAC), triceps skin 
fold (TSF), Lumbar Index, Psoas muscle mass, and the Nutrition Focused Physical Exam 
(NFPE). These results will be compared to liver disease diagnosis and model for end stage 
liver disease (MELD) score. After receiving approval by the University of Kentucky’s 
IRB panel, the study was conducted. The study is summarized and described below. 
1. The research team obtained consent from patients who are deemed appropriate 
for transplant evaluation.  
2. The liver transplant team’s scheduling coordinators randomly assigned the 
liver transplant dietitian evaluations between the Registered Dietitians (RD) in 
the clinic.  
3. A RD completed all patient assessments during their initial consult, including 
NFPE, SGA, MAC, and TST.  
4. Following a CT scan completed during the patient’s initial clinic evaluation, 
the research team completed Lumbar Index and Psoas Muscle Area 
assessments. 
5. The research team maintained contact with the patients’ nurse coordinators for 
three-month endpoints, such as incidence of death, listing for transplant, 
transplant, development of decompensation, or hospital admissions.  
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Subject Recruitment: 
Patients were referred to clinic for transplant evaluation from outside providers. 
Potential patients were identified from their regularly scheduled clinic visit for liver 
transplant evaluation. After a full discussion of the research to be conducted, consent was 
obtained by the research team before data was collected for the study. Normal protocol 
was followed with all patients regardless of their participation in the study.  
Patients in this study were required to have end stage liver disease and deemed 
appropriate for liver transplant evaluation. They also had to attend a nutrition evaluation 
as part of the standard evaluation process. Patients were excluded from this study if a 
patient did not complete the necessary consent form, attend nutritional evaluation as part 
of their standard evaluation process, or wish to be part of the research study.  
 
Measurements and Procedures: 
All research assessments and procedures were taken during patient’s regularly 
scheduled clinic visit with a RD for liver transplant evaluation. Medical history, MELD, 
medications, and demographics were taken from patient’s charts or during the visit. 
Research assessments and procedures are listed below. 
1. Nutrition Focused Physical Exam (NFPE): The RD administered a physical 
exam to assess for muscle loss, fat loss, energy intake, weight loss, fluid 
accumulation (related to malnutrition), and hand grip strength. Muscle loss 
and fat loss are determined using the Nutrition Focused Physical Exam Pocket 
Guide (2015) guidelines and RD’s clinical judgement. Two of the six 
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characteristics are needed to make a diagnosis of malnutrition, and can be 
used to determine severe vs. non-severe malnutrition.[26] Patients were sitting 
upright during assessment and a RD measured for fat loss/muscle in various 
parts of the body by gentle touch and manipulation. If any areas of body 
needed for assessment were unable to be accessed due to clothing, injury, 
edema, or pain, the RD did not assess the area. Energy intake was evaluated 
by asking questions on appetite, average % of meals consumed, and duration 
that patient has been eating in this manner. Weight loss was calculated based 
on dry weights (if available) per patient or by chart review. Hand grip strength 
was assessed using a dynamometer in both hands. Patient squeezed the 
dynamometer with as much strength as possible in each hand, being careful to 
only squeeze once for the measurement. Each measurement was recorded to 
the nearest pound or kilogram. 
2. Patient Generated-Subjective Global Assessment (PG-SGA): The PG-
SGA is a validated tool that expands on the original SGA and was chosen over 
the SGA due to the more extensive range of nutrition symptoms and physical 
assessment. The PG-SGA assessment data was completed by the RD with the 
help of the patient. Data in the assessment includes: weight changes, dietary 
intake, gastrointestinal symptoms, functional capacity, physical examination 
of fat and muscle loss, edema related to malnutrition, and ascites related to 
malnutrition. The physical examination of fat and muscle loss is very similar 
to the NFPE, including gentle touch and manipulation of the same body areas, 
and did not need to be repeated. Results from the physical exam were used for 
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both NFPE and PG-SGA. If any areas of body needed for assessment were 
unable to be accessed due to clothing, injury, edema, or pain, the RD did not 
assess the area. 
3. Triceps Skin Fold (TSF): The RD located the site midway between the 
acromial (shoulder) and elbow. The skin fold was grasped as a vertical fold on 
the posterior midline and pulled it away from the muscle. Millimeters of the 
skin fold were assessed. If measurements were below the “normal” range, 
patients were considered to have malnutrition. The following ranges were 
considered normal. [27] 
 Male: 12.5-7.3 mm 
 Female: 16.5-9.9 mm 
4. Mid Arm Circumference (MAC): The circumference was measured at the 
mid-point between the shoulder and the elbow. The circumference was 
assessed for muscle mass. If measurements were below the “normal” range, 
patients were considered to have malnutrition. The following ranges were 
considered normal.[27] 
 Male: 29.3-17.5 cm 
 Female: 28.5-17.1 cm 
5. Lumbar Index: Patients being evaluated for liver transplant received a CT 
scan as part of their transplant evaluation. The Lumbar Index is total muscle 
surface area at L3 and was evaluated for muscle loss. If measurements were 
below the “normal” range, patients were considered to have sarcopenia. The 
following ranges were considered normal.[5] 
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 Males:  52.4 cm2/m2 
 Females:  38.5 cm2/m2 
6. Psoas Muscle Area: Patients being evaluated for liver transplant received a 
CT scan as part of their transplant evaluation. Psoas muscle surface area at L3 
was evaluated for muscle loss. If measurements were below the “normal” 
range, patients were considered to have sarcopenia. The following ranges 
were considered normal.  
 Males:  545 mm2/m2 
 Females:  385 mm2/m2 
7. Additional data collected: The RD asked additional questions and collected 
data on whether the patient is consuming protein supplements at home and if 
they have had previous diet education pertaining to their liver disease. 
Albumin levels were also recorded and drawn as part of the patient’s routine 
lab work for their transplant evaluation.  
 
Analysis: 
Results of the nutrition assessment and radiological data were analyzed by a 
member of the research team. Data was analyzed by the research team using SPSS 
software version 24 (IBM Inc., Armonk, NY, USA). Data was assessed for normal 
distribution, incomplete data, and inaccurate data. Means were compared using the 
Mann-Whitney Test. A Spearman’s rho test was conducted to assess for correlation 
between the different malnutrition tools. A Fisher’s Exact test was used to compare 
malnutrition to patient characteristics such as disease, decompensation, and outcomes 
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such as decompensation, listing for transplant, hospital admission, transplant, and death. 
An additional logistic regression test was ran to investigate the relationship between 
hospital admissions and malnutrition. A p-value of 0.05 or less was determined to be 
significant.  
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Chapter 4: 
Results 
Thirty-one patients undergoing liver transplant evaluation and who met inclusion 
criteria, participated in this research study. The majority of the participants were male 
(77%) and caucasian (96.8%). The median age was 54 years old, with the youngest 
participant at 29 years old and the oldest 69 years old. The median BMI was 28.8, with a 
range of 15.8-43.9. The median MELD score was (18 6.63) and albumin level (g/dL) 
was (2.71.3). These patient characteristics are shown below in Table 3. 
Table 3: Age, Sex, Race, MELD, BMI, and Albumin Level Characteristics of Study 
Sample 
 n % Median Std. Deviation Min Max 
Age - - 54 9.9 29 69 
Sex                           Male 
                              Female 
24 
7 
77.4% 
22.6% 
- 
- 
- 
- 
- 
- 
- 
- 
Race                 Caucasian 
            African-American 
30 
1 
96.8% 
3.2% 
- 
- 
- 
- 
- 
- 
- 
- 
MELD - - 18 6.63 7 34 
BMI - - 28.8 6.62 15.8 43.9 
Albumin (g/dL) - - 2.7 0.73 1.3 4.0 
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Table 4: Diagnosis and Decompensation in Study Sample 
 n % 
Diagnosis   
Autoimmune Hepatitis 1 3.2% 
Cryptogenic 3 9.7% 
Alcohol 15 48.4% 
Hepatitis C 2 6.4% 
NASH 10 32.3% 
Secondary Diagnosis  
None 27 87.1% 
HCC 
Autoimmune Hepatitis
3 
1 
9.7% 
3.2% 
Decompensation 
Ascites
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96.8% 
Esophageal Varices 22 71% 
Hepatic Encephalopathy 19 61.3% 
Large Volume Paracentesis 21 67.8% 
Hepatorenal Syndrome 3 9.7% 
Spontaneous Bacterial Peritonitis 3 9.7% 
Acute Kidney Injury 1 3.2% 
Hepatopulmonary Syndrome 1 3.2% 
Chronic Kidney Disease 5 16.1% 
 
The majority of these patients either had a diagnosis of alcohol related cirrhosis 
(48.4%) or NASH cirrhosis (32.3%). Only four patients had a secondary diagnosis such 
as HCC (n=3) or autoimmune hepatitis (n=1). Almost every single patient had a history 
of ascites (n=30), and more than half of all patients had history of esophageal varices, 
hepatic encephalopathy, or large volume paracentesis. Nearly one-third of the patients 
had some form of cirrhosis-related kidney disfunction such as hepatorenal syndrome 
(HRS), acute kidney injury (AKI), or chronic kidney disease (CKD). Table 4 contains 
these and further diagnoses.  
When examining the association between MELD score and cirrhosis diagnosis, 
there was a higher median MELD score seen in cryptogenic cirrhosis patients than 
alcohol (ETOH) and NASH patients, but there was a wide variability in MELD scores in 
each cirrhosis group. Autoimmune hepatitis and Hepatitis C patient groups were excluded 
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from this analysis due to their small number size (n=1 and n=2, respectively). The results 
are show in Figure 1 below. 
 
Figure 1: MELD Score and Cirrhosis Diagnosis 
 
When examining data on nutrition related variables, only (32.3%) of the patients 
endorsed “good” appetite, while the rest noted fair, poor, or no appetite at all. However, 
over half of all patients (67.8%) stated that they had some sort of weight loss prior to 
evaluation. The median percent body weight loss was (10.8% 9.64), with the highest 
amount of percent weight loss at (32.6%). In addition, only 12 patients (38.7%) indicated 
that they consumed some sort of protein supplement on a regular basis. Furthermore, 
roughly one-third of these patients (35.5%) had never had any type of nutrition-related 
diet education. Table 5 shows these results. 
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Table 5: Nutrition Related Variables in Study Sample 
Variable n % Median Std. Deviation Min Max 
Appetite 
Good 
Fair 
Poor 
None 
 
10 
13 
7 
1 
 
32.3% 
41.9% 
22.6% 
3.2% 
 
- 
- 
- 
- 
 
- 
- 
- 
- 
 
- 
- 
- 
- 
 
- 
- 
- 
- 
Protein Supplement 12 38.7% - - - - 
Previous Diet Education 20 64.5% - - - - 
Weight Loss 21 67.8%     
% Weight Loss - - 10.8 9.64 0 32.6 
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NFPE Diagnosis of Malnutrition and Patient Characteristics: 
 
 Table 6: Comparison of NFPE Diagnosis of Malnutrition with Decompensation, Patient 
Outcomes, MELD score, and Albumin levels.  
 
  NFPE Diagnosis of Malnutrition  
  No (n = 7) Moderate (n 
= 12) 
Severe (n = 
12) 
p-
value 
Diagnosis Autoimmune 0 (0.0%) 0 (0.0%) 1 (8.3%) 0.027* 
Cryptogenic 0 (0.0%) 0 (0.0%) 3 (25.0%) 
Alcohol 4 (57.1%) 6 (50.0%) 5 (41.7%) 
Hepatitis C 2 (28.6%) 0 (0.0%) 0 (0.0%) 
NASH 1 (14.3%) 6 (50.0%) 3 (25.0%) 
Decompensation Ascites 6 (85.7%) 12 (100.0%) 12 (100.0%) 0.226 
EV 7 (100.0%) 7 (58.3%) 8 (66.7%) 0.210 
HE 5 (71.4%) 9 (75.0%) 5 (41.7%) 0.255 
LVP 4 (57.1%) 8 (66.7%) 9 (75.0%) 0.884 
HRS 1 (14.3%) 1 (8.3%) 1 (8.3%) 1.000 
SBP 0 (0.0%) 1 (8.3%) 2 (16.7%) 0.776 
AKI 0 (0.0%) 0 (0.0%) 1 (8.3%) 1.000 
HP 0 (0.0%) 1 (8.3%) 0 (0.0%) 1.000 
CKD 1 (14.3%) 0 (0.0%) 4 (33.3%) 0.082 
Outcomes Decompensation - - -  
 Listing 2 (28.6%) 4 (33.3%) 5 (41.7%) 0.899 
 Hospital 
Admission
1 (14.3) 6 (50.0%) 11 (91.7%) 0.002* 
 Transplant 0 (0.0%) 3 (25.0%) 1 (8.3%) 0.413 
 Death 0 (0.0%) 0 (0.0%) 3 (25.0%) 0.106 
MELD 14.00 
(13.00-
27.00) 
17.00 (12.25-
19.75) 
21.50 
(14.25-
25.75) 
0.432 
Albumin (g/dL) 2.80 (2.40-
3.60) 
2.70 (2.43-
3.43) 
2.15 (2.00-
3.05) 
0.382 
* indicates statistically significant 
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Figure 2: MELD Score and Malnutrition 
(In the moderate group, the highest MELD was excluded from the plot as 
an outlier) 
 
Based on the dietitian-conducted NFPE, 24 patients had a malnutrition diagnosis 
of moderate or severe malnutrition. The results of the NFPE were then compared to 
cirrhosis diagnosis, decompensation, patient outcomes, MELD score, and albumin level. 
As a result of the small sample size (n=31), a Fisher’s Exact Test was used for analysis in 
the majority of variables. A Mann-Whitney test was used when comparing albumin and 
MELD scores. There was no relation between types of decompensation, MELD score, or 
albumin levels and malnutrition (p > 0.05). However, higher median MELD scores were 
found in those with malnutrition than those without. Median MELD score also increased 
with severity of malnutrition. While albumin levels were not found to be significantly 
associated with malnutrition, the median albumin levels were higher in the group without 
malnutrition compared to those with malnutrition (2.80, 2.70 and 2.15 respectively). In 
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addition to this, albumin levels decreased as severity of malnutrition increased (Table 6). 
In comparison, disease diagnosis was found to be significantly related to malnutrition (p 
= 0.027). Lastly, when comparing malnutrition to patient outcomes, only hospital 
admission was found to be significantly associated with malnutrition (p = 0.002). 
 Additional analyses were conducted comparing presence of malnutrition and 
severe malnutrition to hospital admissions due to the high level of significance found in a 
previous analysis. A logistic regression analysis was conducted for each, and was 
adjusted for age, gender, and albumin levels. The odds-ratio for hospital admission based 
on malnutrition and severe malnutrition were both extremely high (14.571, 18.857 
respectively) and were found to both be significant (p < 0.05). Caution is warranted in 
interpreting these results, as the small sample size and increased variation, leads to wide 
confidence intervals.  Table 7 and 8 reflect these results.  
Table 7: Hospital Admission and Malnutrition 
 
                        Table 8: Hospital Admission and Severe Malnutrition 
Binary Logistic Regression on Hospital Admission 
 B S.E. Wald Sig. OR 
95% C.I.for OR 
Lower Upper 
Malnutrition 2.679 1.170 5.245 .022* 14.571 1.472 144.280
Constant -1.792 1.080 2.752 .097 .167   
 The variables age, gender and ALB were eliminated from the model after model selection.  
*Indicates statistical significance 
Binary Logistic Regression on Hospital Admission 
 B S.E. Wald Sig. OR 
95% C.I.for OR 
Lower Upper 
Severe Malnutrition 2.937 1.148 6.549 .010 18.857 1.989 178.796
Constant -.539 .476 1.284 .257 .583   
 The variables age, gender and ALB were eliminated from the model after model selection.  
*Indicates statistical significance 
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Comparison of NFPE to Additional Assessment Tools 
Table 9: Malnutrition Compared to Additional Tools 
 
Correlation Malnutrition   
NFPE Results N (n = 7) Y (n = 21)* Spearman’s rho 
Based on TPA 2 (28.6%) 12 (57.1%) 0.247 
Based on L3 SMI 6 (85.7%) 19 (90.5%) 0.067 
Less than 25% of L3 0 (0.0%) 7 (33.3%) 0.333 
 N (n = 7) Y (n = 24) Spearman’s rho 
SGA stage                            A 
                                              B 
                                              C 
5 (71.4%) 0 (0.0%) 0.669 
2 (28.6%) 13 (54.2%) 
0 (0.0%) 11 (45.8%) 
TSF-I 1 (14.3%) 5 (20.8%) 0.069 
MAC-I 0 (0.00%) 0 (0.00%) - 
*3-missing CT 
L3 SMI represents Lumbar Index 
 
Table 10: Severe Malnutrition Compared to Additional Tools 
 
Correlation Severe Malnutrition  
NFPE Results N (n = 19) Y (n = 9)* Spearman’s rho 
Based on TPA 7 (36.8%) 7 (77.8%) 0.382 
Based on L3 SMI 16 (84.2%) 9 (100.0%) 0.238 
Less than 25% of L3 2 (10.5%) 5 (55.6%) 0.486 
 N (n = 7) Y (n = 24) Spearman’s rho 
SGA stage                            A 
                                              B 
                                              C 
5 (26.3%) 0 (0.0%) 0.760 
13 (68.4%) 2 (16.7%) 
1 (5.3%) 10 (83.3%) 
TSF-I 3 (15.8%) 3 (25.0%) 0.114 
MAC-I 0 (0.00%) 0 (0.00%) - 
*3-missing CT 
L3 SMI represents Lumbar Index 
 
 
 In addition to the NFPE, multiple additional tools were used to assess 
malnutrition in this study for comparison, including the Lumbar Index, psoas muscle 
area, PG-SGA, TSF, and MAC. Three participants did not have a CT scan as part of their 
evaluation, and their data was excluded for the CT/NFPE comparison portion of the 
analysis. After using the CT scans to assess for sarcopenia, fourteen patients were shown 
to have sarcopenia based on total psoas muscle area (TPA) and twenty-five participants 
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were found to have sarcopenia using the Lumbar Index. There were six participants who 
had a TSF below normal limits, which was considered malnourished. All participants had 
a MAC that was found to be within normal limits, and therefore considered without 
malnutrition. Out of the thirty-one participants, twenty-six participants were found to 
have some degree of malnutrition (Stage B or C) based off of the PG-SGA, and eleven of 
those participants were found to have severe malnutrition (Stage C). Tables 9 and 10 
shows how each of the malnutrition assessment tools compared to the NFPE results.  
 A Spearman’s rho test (rs) was used to assess strength and direction of correlation 
between each of these tools and the NFPE. A diagnosis of malnutrition versus no 
malnutrition using the NFPE, was compared against whether or not malnutrition was 
found using the TPA, L3 SMI, TSF, PG-SGA, and MAC. An additional analysis was run 
comparing patients who had severe malnutrition using the NFPE, to the lowest quartile 
measurements of TPA, L3 SMI, and TSF and Stage C of the PG-SGA. There was a 
strong, positive correlation (rs = 0.669) between NFPE malnutrition and PG-SGA 
classified malnutrition. This correlation was increased (rs = 0.760) when comparing 
severe malnutrition using the NFPE to PG-SGA classified severe malnutrition (Stage C). 
When comparing TPA and L3 SMI to NFPE classified malnutrition, there was a very 
weak correlation between each test, except when comparing the bottom 25% quartile of 
the L3 SMI to severe malnutrition using the NFPE. This resulted in a moderate 
correlation (rs = 0.486) between the two measures. An additional test was completed to 
compare L3 SMI measurements to NFPE malnutrition diagnosis. Table 11 reflects these 
results. There was a significant (p = 0.027) association between L3 SMI and NFPE 
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diagnosis of malnutrition. However, there was no correlation seen between L3 SMI and 
severe malnutrition.  
Table 11: L3 SMI and NFPE Malnutrition Diagnosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L3 SMI (cm2/m2) 
 Malnutrition  
 N (n = 7) Y (n = 21)† p-value 
Mean ± S.D. 45.01 ± 10.25 34.29 ± 10.23 0.027* 
Median (Q1, Q3) 46.72 (36.82, 48.99) 35.80 (29.78, 39.83) 0.385 
 Severe Malnutrition  
 N (n = 19) Y (n = 9)† p-value 
Mean ± S.D. 38.91 ± 8.48 32.87 ± 15.04 0.357 
Median (Q1, Q3) 37.57 (32.29, 43.16) 31.46 (24.73, 45.69) 1.000 
†3-missing CT 
35
 
Chapter 5: Discussion 
 Malnutrition is a very common medical condition that is seen in a variety of 
settings. It can greatly affect patient outcomes and is often hard to diagnosis and assess. 
This is mainly due to the wide variety of methods and techniques available, many of 
which are often unreliable or inconsistent.[12]  In 2012, the NFPE was developed for 
dietitians to aid physicians in a nutrition-based diagnosis of malnutrition. Since its 
development, there have been very few research studies using the NFPE.[13]  
One particular setting that assessment of malnutrition is increasingly difficult, is 
in patients with cirrhosis or ESLD. These patients are at high risk for developing 
malnutrition due to a variety of disease-related side effects such as ascites, nutritional 
deficiencies, and increased metabolic demand. The quest for a reliable and valid tool for 
assessing malnutrition in ESLD, is an ever-growing topic in research.[4-10, 15, 17, 18, 
22, 25, 28, 29] The purpose of this study was to assess malnutrition in ESLD patients 
being evaluated for transplant. It is important to assess malnutrition in this patient 
population because of the effect malnutrition has on mortality and pre/post-transplant 
outcomes. ESLD patients have an increased of developing malnutrition and aggressive 
nutrition intervention can greatly affect patient outcomes. This study assessed 
malnutrition using a variety of tools and methods such as NFPE, Lumbar Index, TPA, 
MAC, and TSF.  The NFPE is advantageous over other tools because of how simple, 
quick, and inexpensive the tool is compared to others and can be easily repeated. In 
addition, the NFPE can be especially beneficial in this patient population since other 
previously studied tools either were too expensive or unreliable in ESLD patients. 
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Malnutrition was also examined in its relation to ESLD diagnosis, MELD, 
decompensation, patient outcomes, and lab values.  
 
Malnutrition Prevalence 
Malnutrition was found in 77% of this patient population using the NFPE, in 
comparison to 84% using PG-SGA, 19.3% using TSF, 50% using TPA, and 89.3% using 
L3 SMI. These results reflect the high incidence of malnutrition in this patient population 
and the wide variability in malnutrition diagnosis, mainly due to the lack of a 
standardized, all-encompassing tool. However, many of these tools were correlated with 
each other in determining malnutrition. These relationships will be further discussed in 
the following sections.  
Appetite changes and weight loss was also found in the majority of participants. 
Both are risks factor for developing malnutrition. In comparison, less than half of these 
patients were using protein supplements to supplement their decreased intake, and over a 
quarter of this population had never had a previous diet education. This is alarming 
considering the overwhelming occurrence of malnutrition in this patient population and 
the prevalence of factors like decompensation that can greatly affect nutritional intake. 
Especially since poor nutritional status is linked to poor outcomes before and after 
transplant.[4-6, 8, 9] This indicates a need for earlier nutrition intervention to assist with 
symptom management and proper nutrition therapy for ESLD patients.  
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Malnutrition and Liver Disease 
 The relationship between the NFPE diagnosed malnutrition and ESLD diagnosis, 
decompensation, and patient outcomes was also examined in this study. ESLD diagnosis 
was found the be significantly associated with malnutrition diagnosis in this patient 
population. There were not enough participants to determine which diagnosis was linked 
to an increased risk of malnutrition. A larger sample size may further examine if certain 
ESLD diagnoses increases the risk of developing malnutrition.  
Although there was a significant association between ESLD diagnosis and 
malnutrition, there were no decompensation characteristics that were linked to 
development of malnutrition. However, a larger sample size may find an association 
between specific decompensation symptoms and incidence of malnutrition.  
Additionally, albumin levels, a common tool used to previously diagnose 
malnutrition, had no significant correlation with the NFPE malnutrition diagnosis. While 
median albumin levels were found to be higher in non-malnourished patients, there were 
still a wide variation in albumin levels for each malnutrition categories. Albumin is not a 
reliable indicator of nutritional status, which is also reflected in these results.  
Similar to the albumin results, higher median MELD scores were shown in those 
with malnutrition versus. those without. This could reflect the increased risk of 
developing malnutrition as ESLD worsens or the possibility that the presence of 
malnutrition worsens ESLD. While MELD has been found to be a good tool to predict 
mortality in ESLD patients, it does not reflect additional factors that affect mortality such 
as malnutrition. Possible future studies using a MELD score with a malnutrition 
component should be considered.  
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 Malnutrition using the NFPE was also compared to patient outcomes such as 
transplant listing, decompensation, hospital admission, transplant, and death. Only 
hospital admissions were found to be correlated with a malnutrition diagnosis. There was 
also an extremely high odds-ratio for hospital admission, which increased with the 
severity of malnutrition. Patients with a diagnosis of malnutrition were roughly 1,400% 
more likely to be admitted to the hospital, and roughly 1,900% more likely with a 
diagnosis of severe malnutrition. However, due to the small patient population, this data 
is limiting. More research will need to be conducted to evaluate this relationship. If 
similar results are found in future studies, this could signify the importance of an earlier 
nutrition intervention, including the RD screening for malnutrition and more aggressive 
nutrition care, to prevent negative patient outcomes such as hospital admissions. 
 
PG-SGA 
Previous studies have used SGA to assess malnutrition in cirrhosis patients with 
positive results. While the SGA and PG-SGA are not the exact same tool, the PG-SGA is 
an expanded version of the SGA. In this study, the NFPE was found to be strongly 
correlated with the PG-SGA in both diagnoses of malnutrition and severity of 
malnutrition. In addition, the PG-SGA in this study, provided similar results to those that 
were seen with the SGA in cirrhotic patients in other studies. [6, 15] In these previous 
studies, malnutrition determined by the SGA, was also associated with poor patient 
outcomes. This study found similar results when examining the role of NFPE identified 
malnutrition and hospital admissions.  
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These results strengthen the NFPE as a valid tool to assess malnutrition in ESLD 
patients. Additionally, the NFPE is a quick, simple tool compared to the PG-SGA and 
can be conducted in a variety of settings. The PG-SGA relies heavily on patient recall 
which could possibly skew results and could be inaccurate depending on literacy level or 
patient understanding. In comparison, the NFPE is completed by a trained RD and patient 
recall is only a small portion of the exam. The NFPE also relies heavily on the physical 
exam, while the physical exam is only a small part of the PG-SGA. More research will 
need to be conducted with the NFPE to study its validity.  
 
TSF and MAC 
 TSF and MAC are standardized tools that have been used to assess malnutrition in 
many studies involving cirrhotic patients. In this study, there were no patients that had a 
MAC below normal limits to indicate malnutrition. Malnutrition was indicated in six 
patients using TSF parameters. Both of these tools under-diagnosed malnutrition 
compared to the NFPE and PG-SGA. This indicates that the TSF and MAC may not be 
reliable tools to assess malnutrition in ESLD patients. The majority of this population 
were overweight or obese, likely skewing the effectiveness of these tools.  A larger 
sample size may collaborate these results. 
 
L3 SMI and TPA 
 Overall, sarcopenia was found in the majority of the patients in this study after 
examining the TPA and L3 SMI. In comparison to the NFPE, there was a poor 
correlation between most of the studies and the NFPE diagnosed malnutrition. However, 
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moderate correlation was found between severe malnutrition using the NFPE and the 
lowest quartile of the L3 SMI. It is likely that the correlation between these tests would 
increase with a larger sample size. The mean L3 SMI was also found to be significantly 
associated with malnutrition diagnosis. These are promising results. If the NFPE is found 
to be a valid tool to measure sarcopenia, the ability to diagnose malnutrition in this 
patient population would be substantially altered. Since sarcopenia is often masked in 
these patients due to ascites and edema this would be of great benefit to those making 
assessments. As with the previously discussed tools, future studies with larger sample 
sizes, will need to be conducted.  
 
Conclusion 
 In conclusion, malnutrition is a consistent problem in most patient populations. 
There have been numerous tools used over the years used to diagnose malnutrition, but 
many of these tools have been found to be unreliable and inconsistent. The need for a 
standardized tool that encompasses a variety of measures and can be used in all patient 
populations, has been ever-growing. In 2012, the NFPE was developed for dietitians to 
aid physicians in a nutrition-focused malnutrition diagnosis. However, there have been 
very few research studies using this NFPE to assess malnutrition.  
Based on the results of this study, the validity of this tool is very promising. The 
validity of the NFPE was examined by comparing its results to other malnutrition tools.  
The NFPE has been shown to correlate with other tools such as the invasive L3 SMI 
measure for sarcopenia and the PG-SGA/SGA, which has been validated in other studies. 
In addition, the NFPE diagnosed malnutrition was found to be significantly associated 
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with hospital admissions. Due to the small patient population of this study, more research 
will need to be conducted to support these results.  
Sample size and number of patients without malnutrition were limitations to this 
study. The majority of the patients examined were white and males, therefore limiting the 
generalizability of the results. The NFPE was also limited in this study from inability to 
collect data on all physical locations due to ascites, clothing, or injury. There was also 
likely inaccuracy in assessing weight status and energy intake due to patient recall. While 
there were many limitations in this study, the use of multiple malnutrition tools for 
comparison was a strength in this study. These tools were comprised of both objective 
and subjective tools which was another strength. Additionally, inclusion/exclusion 
criteria and patient randomization between RDs limited possible biases. Lastly, 
comparing NFPE-diagnosis to patient outcomes showed the benefits of using this tool.  
These preliminary results reinforce the significance of the NFPE and the need for 
additional studies using this tool. The NFPE also stresses the importance of the RD in the 
medical field, and how an earlier dietitian screening and intervention could improve 
patient outcomes, such as reduced hospital admissions, reduced incidence and severity of 
malnutrition, and decreased risk of mortality, especially in patients with ESLD. 
Furthermore, using MELD score to predict mortality in ESLD patients needs to be re-
evaluated.  As compared to previous research, MELD is not associated with liver disease 
diagnosis or incidence of malnutrition. However, adding a nutritional component to 
MELD scoring could potentially improve the accuracy of mortality risk and prioritization 
of transplant patients on the wait list. More research using the NFPE will need to be 
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conducted in not only ESLD patients, but other patient populations, before the NFPE can 
be considered the “gold standard” for diagnosing malnutrition.  
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Appendix A: List of Abbreviations 
Abbreviation Explanation 
AND Academy of Nutrition and Dietetics  
ASPEN American Society for Parenteral and Enteral Nutrition 
CTP Child-Turcotte-Pugh Score 
ESLD End Stage Liver Disease 
EV Esophageal Varices 
HCC Hepatocellular Carcinoma 
HE Hepatic Encephalopathy 
HRS Hepatorenal Syndrome 
L3 PMI Lumbar Psoas Muscle Index 
L3 SMI Lumbar Index 
LVP Large Volume Paracentesis 
MAC Mid-Arm Circumference  
MAMC Mid-Arm Muscle Circumference 
MELD Model for End Stage Liver Disease 
NAFLD Non-Alcoholic Fatty Liver Disease  
NASH Non-Alcoholic Steatohepatitis  
NFPE Nutrition Focused Physical Exam 
PG-SGA Patient Generated-Subjective Global Assessment 
RFH-GA Royal Free Hospital Global Assessment 
RD Registered Dietitian 
SBP Spontaneous Bacterial Peritonitis 
SGA Subjective Global Assessment 
TIPS Transjugular Intrahepatic Portosystemic Shunt 
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TSF Triceps Skin Folds 
UNOS United Network for Organ Sharing 
 
 
Appendix B: NFPE: Clinical Characteristics to Identify and Support a Diagnosis of 
Malnutrition[26] 
Clinical 
Characteristic 
Malnutrition in the context of 
acute illness or injury 
Malnutrition in the context 
of chronic illness 
Malnutrition in the context of 
social or environmental 
circumstances 
  
Non-severe 
(moderate) 
malnutrition 
Severe 
Malnutrition 
Non-severe 
(moderate) 
malnutrition 
Severe 
Malnutrition 
Non-severe 
(moderate) 
malnutrition 
Severe 
Malnutrition 
Energy Intake 
<75% of 
estimated 
energy 
requirement 
for > 7 days 
< 50% of 
estimated 
energy 
requirement 
for  5 days 
< 75% of 
estimated 
energy 
requirement 
for  1 
month 
< 75% of 
estimated 
energy intake 
for  1 
month 
< 75% of 
estimated 
energy 
requirement 
for  3 
months 
£ 50% of 
estimated 
energy 
requirement 
for  1 
month 
Interpretation 
of Weight 
Loss 
% Time % Time % Time % Time % Time % Time 
1-2 1 week >2 1 week 5 
1 
month 
>5 
1 
month 
>5 
1 
month 
>5 
1 
month 
5 
1 
month 
>5 
1 
month 
7.5 
3 
months 
>7.5 
3 
months 
>7.5 
3 
months 
>7.5 
3 
months 
7.5 
3 
months 
>7.5 
3 
months 
10 
6 
months 
>10 
6 
months 
>10 
6 
months 
>10 
6 
months 
       20 1 year >20 1 year >20 1 year >20 1 year 
Physical Findings 
Body Fat Mild Moderate Mild Severe Mild Severe 
Muscle Mass Mild Moderate Mild Severe Mild Severe 
Fluid 
Accumulation 
Mild 
Moderate to 
Severe 
Mild Severe Mild Severe 
Reduced Grip 
Strength 
N/A 
Measurably 
Reduced 
N/A 
Measurably 
Reduced 
N/A 
Measurably 
Reduced 
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Appendix C: Summary of Common Liver Disease Diagnoses[2, 3] 
Type of Liver 
Disease 
Cause of Liver 
Disease 
At Risk 
Populations/Risk 
Factors 
Treatment/Cure 
Hepatitis B and C 
Hepatitis is a virus 
that can be 
transmitted through 
bodily fluids (semen, 
blood, and vaginal 
secretions) 
• IV drug use 
• Unprotected sex
• Body piercings 
• Tattoos 
• Incarceration  
• Hepatitis can be cured spontaneously by 
the body and through pharmaceuticals. 
• There is currently a vaccine for 
Hepatitis B, but not for Hepatitis C. 
• When a patient with the hepatitis virus 
fails treatment, or waits too long to seek 
treatment, it can lead to liver damage and 
ultimately liver failure. This can only be 
treated with transplant.  
Acute Liver Failure 
Drug overdose 
(acetaminophen), 
drug 
toxicity/reaction, 
herbal supplements, 
viruses, cancer, 
metabolic diseases 
• High 
acetaminophen 
use 
• Herbal use 
• Cancers with 
high risk of liver 
metastasis 
development 
• Liver Cancer 
• Metabolic 
Disorders  
• Medications to reverse poisoning 
• Transplant  
Autoimmune 
Hepatitis 
Immune system 
attacks liver cells 
causing inflammation 
and damage 
• Women 
between the ages 
15-40 
• Other 
autoimmune 
diseases 
• Suppress immune system with steroids 
or other immunosuppressant drugs 
• Transplant 
Alcoholic Liver 
Disease 
Alcohol abuse 
• Alcoholics 
• Those with long 
history of 
frequent alcohol 
use 
• Alcohol cessation 
• Transplant  
Nonalcoholic Fatty 
Liver 
Disease/Nonalcoholic 
Steatohepatitis 
Build-up of fat cells 
in the liver 
• Obesity 
• Diabetes 
• High cholesterol
• Unhealthy diet 
• Healthy diet and exercise 
• Weight loss if overweight/obese 
• Transplant 
Hepatocellular 
Carcinoma 
Liver Cancer 
• Pre-existing 
cirrhosis 
• Long term 
hepatitis virus 
• Resection 
• Chemoembolization 
• Ablation 
• Treatment of hepatitis or underlying 
cirrhosis  
• Transplant 
 
 
 
   
Primary Biliary 
Cirrhosis 
Destruction of 
intrahepatic bile 
ducts leads to build 
• Women 
• Middle age 
• Symptom management with 
medications 
• Transplant 
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up of bile and scar 
tissue, damaging the 
liver. 
adults 
• Genetics 
Primary Sclerosis 
Cholangitis 
Blocked bile ducts 
due to scar tissue and 
inflammation leads to 
buildup of bile, 
damaging the liver. 
• Men 
• Genetics 
• Exact cause 
unknown 
• Symptom management with 
medications and surgery 
• Transplant  
Other (less common) 
Wilson’s Disease, 
Hemochromatosis, 
Alpha-1  
Anti-trypsin 
Deficiency, 
Undetermined cause, 
etc.  
• Genetics 
• Lifestyle 
• Treatment based on disease.  
• Transplant 
 
 
 
Appendix D: Age, Sex, Race, MELD, BMI, and Albumin Characteristics of Study 
Sample 
 n % Median Std. Deviation Min Max 
Age - - 54 9.9 29 69 
Sex                           Male 
                              Female 
24 
7 
77.4% 
22.6% 
- 
- 
- 
- 
- 
- 
- 
- 
Race                 Caucasian 
            African-American 
30 
1 
96.8% 
3.2% 
- 
- 
- 
- 
- 
- 
- 
- 
MELD - - 18 6.63 7 34 
BMI - - 28.8 6.62 15.8 43.9 
Albumin (g/dL) - - 2.7 0.73 1.3 4.0 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
47
 
Bibliography 
 
1. United Network for Organ Sharing. UNOS.  [cited 2018; Available from: 
http://www.unos.org. 
2. Qamar, A.A., Liver Transplantation, in Current Diagnosis and Treatment: 
Gastroenterology, Hematology, and Endoscopy. 2016, McGraw-Hill Education: 
United States. 
3. American Liver Foundation. Liver Disease Information. 2018  [cited 2018; 
Available from: http://www.liverfoundation.org. 
4. Anastácio, L.R. and M.I.T.D. Correia, Nutrition therapy: Integral part of liver 
transplant care. World journal of gastroenterology, 2016. 22(4): p. 1513. 
5. DiMartini, A., et al., Muscle mass predicts outcomes following liver 
transplantation. Liver Transplantation, 2013. 19(11): p. 1172-1180. 
6. Stephenson, G.R., et al., Malnutrition in liver transplant patients: preoperative 
subjective global assessment is predictive of outcome after liver transplantation. 
Transplantation, 2001. 72(4): p. 666-670. 
7. Ferreira, L.G., et al., Assessment of nutritional status of patients waiting for liver 
transplantation. Clinical transplantation, 2011. 25(2): p. 248-254. 
8. Kalafateli, M., et al., Malnutrition and sarcopenia predict post‐liver 
transplantation outcomes independently of the Model for End‐stage Liver Disease 
score. Journal of cachexia, sarcopenia and muscle, 2017. 8(1): p. 113-121. 
9. Merli, M., et al., Nutritional status and liver transplantation. Journal of clinical 
and experimental hepatology, 2011. 1(3): p. 190-198. 
10. Johnson, T.M., et al., Nutrition assessment and management in advanced liver 
disease. Nutrition in Clinical Practice, 2013. 28(1): p. 15-29. 
11. Jensen, G.L., et al., Recognizing malnutrition in adults: definitions and 
characteristics, screening, assessment, and team approach. Journal of Parenteral 
and Enteral Nutrition, 2013. 37(6): p. 802-807. 
12. White, J.V., et al., Consensus statement of the Academy of Nutrition and 
Dietetics/American Society for Parenteral and Enteral Nutrition: characteristics 
recommended for the identification and documentation of adult malnutrition 
(undernutrition). Journal of the Academy of Nutrition and Dietetics, 2012. 
112(5): p. 730-738. 
13. Mulasi, U., et al., Malnutrition identified by the Academy of Nutrition and 
Dietetics and American Society for parenteral and enteral nutrition consensus 
criteria and other bedside tools is highly prevalent in a sample of individuals 
undergoing treatment for head and neck cancer. Journal of Parenteral and Enteral 
Nutrition, 2018. 42(1): p. 139-147. 
14. Strasser, S.I. and H. Vidot, Nutritional considerations in end‐stage liver disease. 
Journal of gastroenterology and hepatology, 2011. 26(9): p. 1346-1348. 
15. da Silveira, T.R., Comparison between handgrip strength, subjective global 
assessment, and prognostic nutritional index in assessing malnutrition and 
predicting clinical outcome in cirrhotic outpatients. Nutrition, 2005. 21(2): p. 
113-117. 
16. Leise, M.D., W.R. Kim, and P.S. Kamath, Issues in Transplantation of Patients 
with Chronic Liver Failure, in Chronic Liver Failure. 2011, Springer. p. 521-539. 
48
 
17. Tsiaousi, E.T., et al., Malnutrition in end stage liver disease: recommendations 
and nutritional support. Journal of gastroenterology and hepatology, 2008. 23(4): 
p. 527-533. 
18. Tandon, P., et al., Severe muscle depletion in patients on the liver transplant wait 
list: its prevalence and independent prognostic value. Liver Transplantation, 
2012. 18(10): p. 1209-1216. 
19. Malinchoc, M., et al., A model to predict poor survival in patients undergoing 
transjugular intrahepatic portosystemic shunts. Hepatology, 2000. 31(4): p. 864-
871. 
20. Ahmad, J., et al., Impact of the MELD score on waiting time and disease severity 
in liver transplantation in United States veterans. Liver Transplantation, 2007. 
13(11): p. 1564-1569. 
21. United Network for Organ Sharing, Liver Allocation, United Network for Organ 
Sharing, Editor. 2017: Richmond, VA. 
22. Montano–Loza, A.J., et al., Muscle wasting is associated with mortality in 
patients with cirrhosis. Clinical Gastroenterology and Hepatology, 2012. 10(2): p. 
166-173. e1. 
23. Cabral, C.M. and D.L. Burns, Low-protein diets for hepatic encephalopathy 
debunked: let them eat steak. Nutrition in Clinical Practice, 2011. 26(2): p. 155-
159. 
24. Córdoba, J., et al., Normal protein diet for episodic hepatic encephalopathy: 
results of a randomized study. Journal of hepatology, 2004. 41(1): p. 38-43. 
25. Durand, F., et al., Prognostic value of muscle atrophy in cirrhosis using psoas 
muscle thickness on computed tomography. Journal of hepatology, 2014. 60(6): p. 
1151-1157. 
26. Mordarski, B., Nutrition Focused Physical Exam Pocket Guide. 2015: Academy 
of Nutrition and Dietetics. 
27. Timby, B.K., Fundamental nursing skills and concepts. 2009: Lippincott 
Williams & Wilkins. 
28. Carvalho, L. and E.R. Parise, Evaluation of nutritional status of nonhospitalized 
patients with liver cirrhosis. Arquivos de gastroenterologia, 2006. 43(4): p. 269-
274. 
29. Plauth, M., et al., ESPEN guidelines on enteral nutrition: liver disease. Clinical 
nutrition, 2006. 25(2): p. 285-294. 
 
 
 
 
49
Vita 
 
Madison Lynn Hilgendorf, RD, CSO, LD 
 
Education: 
Bachelor of Science in Dietetics, University of Kentucky, Lexington, KY, August 2012 
• University of Kentucky NFS Coordinated Program Internship 
Master of Science in Nutrition and Food Systems (expected), University of Kentucky,   
Lexington, KY, August 2018 
 
Certifications: 
Board Certified as a Specialist in Oncology Nutrition (CSO)     September 2015-Present 
 
Relevant Experience: 
Registered Dietitian, University of Kentucky, Lexington, KY.              July 2016-Present 
• Specialized in Liver and Kidney Transplant 
Registered Dietitian, Pikeville Medical Center, Pikeville, KY.         April 2013-July 2016 
• Specialized in Oncology 
50
